Article Information
- Received February 22, 2019
- Revision received May 7, 2019
- Accepted May 9, 2019
- Published online May 16, 2019.
Author Information
- Zisis Bimpisidis1,
- Niclas König1,
- Stefanos Stagkourakis2,
- Vivien Zell3,
- Bianca Vlcek1,
- Sylvie Dumas5,
- Bruno Giros6,7,8,
- Christian Broberger2,
- Thomas S. Hnasko3,4 and
- Åsa Wallén-Mackenzie1
- 1Department of Organismal Biology, Uppsala University, 75236 Uppsala, Sweden
- 2Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden
- 3Department of Neurosciences, University of California, San Diego, La Jolla, CA
- 4Research Service VA San Diego Healthcare System, San Diego, CA 92161
- 5Oramacell, 8 Rue Grégoire de Tours, 75006 Paris, France
- 6Institut National de la Santé et de la Recherche Médicale, INSERM UMRS 1130; Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8246; Sorbonne University Université Pierre-et-Marie-Curie, Neurosciences Paris-Seine, F-75005, Paris, France
- 7Douglas Mental Health University Institute 6875 LaSalle blvd, Verdun (Qc), H4H 1R3, Montreal, Canada
- 8Department of Psychiatry, McGill University, Montreal, Canada
- Correspondence should be addressed to Åsa Wallén-Mackenzie at asa.mackenzie{at}ebc.uu.se
Author contributions
Author contributions: Å.W.M conceived the study and was in charge of overall direction and planning; Z.B., S.S., V.Z., S.D., C.B., T.S.H., and Å.W.-M. designed research; Z.B., N.K., S.S., V.Z., B.V., S.D., and Å.W.-M. performed research; Z.B., N.K., S.S., V.Z., B.V., S.D., C.B., T.S.H., and Å.W.-M. analyzed data; Z.B. and Å.W.-M. wrote the paper; B.G. contributed transgenic tool.
Disclosures
S.D. is the owner of Oramacell. All other authors declare no competing financial interests.
Work in Å.W.-M. lab was supported by Uppsala University, Vetenskapsrådet (Medicine & Health), Hjärnfonden, Parkinsonfonden, and the Research Foundations of Bertil Hållsten, OE & Edla Johansson, Zoologisk Forskning, and Åhlén. Work in C.B. lab was supported by Vetenskapsrådet (Medicine & Health), the European Research Council, Novo Nordisk Fonden, and the Strategic Research Programme for Diabetes Research at Karolinska Institutet. Work in T.S.H. lab was supported by the National Institutes of Health Grant DA036612 and the Veterans Affairs Grant BX003759.
Funding
hjärnfonden
vetenskapsrådet
Other Version
- You are viewing the most recent version of this article.
- previous version (May 16, 2019).
Article usage
In this issue
